HOME >> MEDICINE >> NEWS
NIAID Ebola vaccine enters human trial

The first human trial of a vaccine designed to prevent Ebola infection opened today. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), designed the vaccine, which was administered to a volunteer at the NIH Clinical Center in Bethesda. The vaccine does not contain any infectious material from the Ebola virus.

Just three years ago, VRC Director Gary Nabel, M.D., Ph.D., together with a team of scientists from the VRC and the Centers for Disease Control and Prevention, described an experimental Ebola vaccine that fully protected monkeys from lethal infection by the virus. One component of that vaccine will now be assessed for safety in human volunteers. The trial vaccine, a type called a DNA vaccine, is similar to other investigational vaccines that hold promise for controlling such diseases as AIDS, influenza, malaria and hepatitis.

"This trial is further evidence of the ability of the VRC to rapidly translate basic research into tangible products," notes NIAID Director Anthony S. Fauci, M.D. "Our accelerated effort to understand and combat Ebola infection is part of the NIAID commitment to its biodefense mission. An effective Ebola vaccine not only would provide a life-saving advance in countries where the disease occurs naturally, it also would provide a
medical tool to discourage the use of Ebola virus as an agent of bioterrorism."

Outbreaks of Ebola in Africa kill up to 90 percent of those infected. No effective treatment exists for this highly infectious disease, which causes extensive internal bleeding and rapid death. According to experts, vaccination is the best strategy for preventing or containing this deadly infection.

A gap of two decades separated the first Ebola epidemic of 1976 and the next, which arose in 1995. In recent years, for reasons unknown, outbreaks of Ebola are occurring with increasing fre
'"/>

Contact: Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
18-Nov-2003


Page: 1 2 3

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2018)... ... November 15, 2018 , ... Associated Urologists ... UroLift® Center of Excellence. The designation recognizes that Dr. Dehner has achieved a ... commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic ...
(Date:11/14/2018)... (PRWEB) , ... November 14, 2018 , ... Acti-Kare ... Searcy, Cabot, Jacksonville, Austin, Ward and Romance, is celebrating its official grand opening with ... Local families are encouraged to like and follow the Acti-Kare Facebook page ...
(Date:11/14/2018)... ... November 14, 2018 , ... Contrary to ... recycled consumer product. Lead batteries hold the honor at a whopping 99.3 percent, ... Day 2018 on November 15, the lead battery industry is proudly sharing the ...
(Date:11/14/2018)... ... November 14, 2018 , ... Nanovis , a leader ... FortiCore® rotatable Posterior Lumbar Interbody Fusion (PLIF) devices. , With over 5,000 FortiCore ... expansion of their FortiCore PLIF product line with the addition of 22 mm and ...
(Date:11/13/2018)... RESEARCH TRIANGLE PARK, N.C. (PRWEB) , ... November ... ... the biopharmaceutical, pharmaceutical, and medical device industries, announced today the opening of its ... Park, Azzur Labs’ state-of-the-art facility aims to provide comprehensive services to top U.S. ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... ... announced today that it is now offering its flagship phishing simulation platform to ... of damaging Security Breaches. The Symbol Platform is designed to seamlessly allow ...
(Date:11/14/2018)... (PRWEB) , ... November 14, ... ... audit, Aspirus Medevac is being awarded accreditation for their ground ... of Medical Transport Applications (NAAMTA). , NAAMTA Accreditation is founded ...
(Date:11/13/2018)... (PRWEB) , ... November 13, 2018 , ... ... the CCW100 pool sanitation system. The pool plumbing Manifold enables homeowners and pool ... are now available to order. , Clear Comfort pool systems can now use ...
Breaking Medicine Technology:
Cached News: